1. HOME
  2. HOME
  3. PIPELINE
  4. DRUG DISCOVERY
 

DRUG DISCOVERY

RevolKa is developing its own drug discovery pipeline targeting inherited metabolic diseases using proprietary designs powered by aiProtein®.

As of January 31, 2025
Project Indication Partner Discovery/Preclinical Clinical
Lead
Discovery
Preclinical Ph1 Ph2 Ph3
RKD001 Rare
Disease
pipeline_1block.jpg        
RKD002 Rare
Disease
       
RKD003 Rare
Disease
       
RKD004 Rare
Disease
Undisclosed        

CONTACT

Please contact from here.